- Technology and Data
- Front End Sales and Marketing
- Allergy
- HIV
- Women's Health
- Migraine
- Compounding
- Continuous Glucose Monitoring
- Mental Health Awareness
- Veterinary Pharmacy
- CBD
- Infectious Disease
- Eye Health
- Digestive Health
- Biosimilars
- Influenza
- Shingles
- COPD Management
- Pediatrics
- Generics
- Pain Management
- COVID-19
- Immunization
- Oncology
- Anticoagulants
- Autoimmune Diseases
- Dermatology
- Diabetes
- Respiratory
- Heart Health
- Cardiovascular Clinical Consult
The Path Forward: Navigating the DSCSA Stabilization Policy
Learn more about the ins and outs of the new DSCSA stabilization policy, delaying some facets of DSCSA implementation to November 2024.
Elizabeth Gallenagh, JD, general counsel and senior vice president of supply chain integrity at the Healthcare Distribution Alliance, Tish Pahl, JD, principal at Olsson Frank Weeda Terman Matz PC, and Scott Mooney, vice president of distribution operations at McKesson, discussed the FDA’s Drug Supply Chain Security Act (DSCSA) stabilization policy, which delays some facets of DSCSA implementation to November 2024.
What Pharmacies Can Expect From Medication Synchronization Programs
November 6th 2023Tiffany Capps, CPhT, pharmacy operations manager at Galloway-Sands Pharmacy in North Carolina and marketing communications manager at CPESN, discusses how pharmacies can utilize med sync programs and what they can expect when implementing one.
